The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•14 April 2026•

1 min read

Abingdon Health to List on US OTCQB Market to Boost Global Presence

Key Facts

1Abingdon Health shares will begin trading on the US OTCQB Venture Market under the ticker ABDXF starting April 21, 2026.

Abingdon Health PLC has announced that its shares will commence trading on the US OTCQB Venture Market under the ticker ABDXF starting April 21, 2026. This cross-listing is designed to increase accessibility for US-based investors, complementing the company's primary listing on the London AIM market. The move follows the strategic expansion of the company's facility in Madison, Wisconsin, which was funded by a successful capital raise in October 2025. By entering the OTCQB market, Abingdon Health aims to broaden its investor base and enhance share liquidity. This dual-listing reflects the company's commitment to strengthening both its physical and financial presence in the United States. Analysts view this as a positive step toward scaling the company's international operations.